Hrt Financial LP Synlogic, Inc. Transaction History

Hrt Financial LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.91 - $14.63 $12,010 - $193,086	13,198 New	13,198 $12,000
Q1 2020 May 15, 2020	SELL	$1.39 - $3.19 $19,389 - $44,497	-13,949 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.96 - $2.81 $27,340 - $39,196	13,949 New	13,949 $35,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.